Endothelial nitric oxide synthase transgenic models of endothelial dysfunction

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Vascular Physiology

Background:

• Endothelial nitric oxide (NO) is vital for regulating vascular tone, blood flow, and preventing atherosclerosis.
• Deficiency in bioavailable NO leads to endothelial dysfunction, promoting thrombosis, inflammation, and vasoconstriction.

Purpose of the Study:

• To review mouse models with genetically modified endothelial nitric oxide synthase (eNOS) genes for studying endothelial dysfunction.
• To analyze the cardiovascular phenotypes of eNOS knockout and eNOS S1177 mutant mice.

Main Methods:

• Focus on genetic modifications of the eNOS gene in mouse models.
• Description of eNOS knockout mice representing total eNOS deficiency.
• Analysis of eNOS S1177A and S1177D mutant mice with altered eNOS phosphorylation.

Main Results:

• eNOS knockout mice serve as a model for complete endothelial dysfunction.
• eNOS S1177 mutant mice exhibit varying degrees of endothelial dysfunction due to altered phosphorylation.
• Transgenic and knockin approaches were used to create these eNOS mutant models.

Conclusions:

• eNOS knockout and eNOS S1177 mutant mice are valuable tools for researching endothelial dysfunction.
• These models facilitate the study of total eNOS deficiency and partial dysfunction.
• Understanding eNOS phosphorylation's role in endothelial dysfunction is advanced by these models.